PPD: Meeting biopharma demand is a ‘substantial undertaking’ for CRO industry

By Melissa Fassbender contact

- Last updated on GMT

PPD Laboratories SVP says its been a substantial undertaking – for every company in the CRO industry – to meet the demand for biopharmaceuticals as the industry's pipeline continues to expand.

“I think it’s no secret within the industry that one of the fastest growing areas of demand for pharmaceutical companies has been their development needs for biopharmaceuticals,” ​said Jon F. Denissen, PhD, senior vice president, PPD Laboratories, at the company’s recently expanded facility in Middleton, WI.

To meet this demand, the contract research organization (CRO) has been expanding capacity globally. Most recently, PPD opened a 32,000 square-foot analytical laboratory, making room for more than 100 new employees.

“It’s been a substantial undertaking I think for every company in the CRO industry to keep up with demand for biopharmaceuticals,”​ Denissen told us after touring the new laboratory.

For a look inside the lab, and to hear more from Denissen on how the company is working to keep up with demand, catch our quick video above.

Related news

Show more

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Related suppliers

Follow us

Products

View more

Webinars